Icon

AUSTEDO XR (NDA216354)- (6MG,12MG,18MG,24MG,30MG,36MG,42MG,48MG)

DEUTETRABENAZINE TEVA
6MG,12MG,18MG,24MG,30MG,36MG,42MG,48MG
No Yes
2041-Jun-10 Expired
None None
None No
AUSTEDO XR is vesicular monoamine transporter 2 (VMAT2) inhibitors indicated in adults for the treatment of: • Chorea associated with Huntington’s disease • Tardive dyskinesia
0 0 0
Total Other Developers None
Drugs with Suitability No
6MG ** ** - - -
12MG ** ** - - -
18MG ** ** - - -
24MG ** ** - - -
30MG ** ** - - -
36MG ** ** - - -
42MG ** ** - - -
48MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.